In order to gather the elements of innovation, gather the wisdom of experts in the innovative drug industry, and build a platform for the exchange of cutting-edge academic ideas on innovative drugs, the "2024 International Pharmaceutical Service Industry Innovation and Development Conference and the 9th China Pharmaceutical R&D and Innovation Summit" was successfully held in Xiongan Convention and Exhibition Center on July 4-5.

The conference was jointly guided by China Pharmaceutical University, China Pharmaceutical Enterprise Management Association, Biomedicine Park Working Committee of China Technology Entrepreneurship Association, and National Pharmaceutical Technology Market Association. Co-sponsored by China Association for the Promotion of International Science and Technology, China Pharmaceutical Magazine, Zhongguancun Help Health Science and Technology Innovation Center, Zhongguancun Zhuoyi Chronic Disease Prevention and Technology Innovation Research Institute, Chongqing University of Posts and Telecommunications, co-organized by China Association for the Promotion of International Science and Technology, Pharmaceutical Intelligence Media, Pharmaceutical Intelligence Consulting. Kangzhou Pharmaceutical Big Data Research Institute, Kangzhou Huitong Human resource management consulting support, MKM Pharmaceutical Think Tank, Beijing Kangzhong Times Group, Nanjing Zhihe Pharmaceutical, Shandong Bainuo Pharmaceutical, Nanjing Weikell, Huayi Pharmaceutical, Stende Pharmaceutical and other enterprises co-organized, focusing on "new drug research and development and clinical trials" frontier issues, It has attracted the participation of many experts, scholars, business executives and industry elites from government, industry, medicine, education, research and capital, to jointly explore the development trend of innovative drugs, biomedical industry chain innovation, cutting-edge technologies, clinical trials, and explore the core value of commercialization of innovative drug enterprises, and contribute to accelerating the high-quality development of China's innovative drug industry.

Source: Pharmaceutical intelligence headlines